[
  {
    "date": "2023-09-30",
    "symbol": "UPC",
    "period": "FY",
    "cash": 5285247,
    "shortterminvestments": 13219005,
    "accountsreceivablenetcurrent": 10667603,
    "otherreceivablesnetcurrent": 61678,
    "inventorynet": 3343266,
    "supplies": 180643,
    "prepaymentforacquisitioncurrent": 3426535,
    "prepaidexpenseandotherassetscurrent": 626241,
    "assetscurrent": 36810218,
    "propertyplantandequipmentnet": 3699965,
    "prepaymentsmadetoarelatedpartyforpurchaseofpropertynoncurrent": 2192982,
    "prepaymentsforconstructioninprogress": 9092996,
    "intangibleassetsnetexcludinggoodwill": 148584,
    "equitymethodinvestments": 685307,
    "deferredincometaxassetsnet": 656980,
    "assetsnoncurrent": 16476814,
    "assets": 53287032,
    "shorttermbankloansandnotespayable": 5482456,
    "accountspayablecurrent": 4585285,
    "taxespayablecurrent": 434758,
    "otherliabilitiescurrent": 540096,
    "accruedliabilitiesandotherliabilities": 2711736,
    "liabilitiescurrent": 13754331,
    "commonstockvalue": 67969,
    "additionalpaidincapitalcommonstock": 29279159,
    "statutoryreserve": 2439535,
    "retainedearningsaccumulateddeficit": 10159304,
    "accumulatedothercomprehensiveincomelossnetoftax": -2413266,
    "stockholdersequity": 39532701,
    "liabilitiesandstockholdersequity": 53287032,
    "commonstockparorstatedvaluepershare": 0.01875,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 3625000,
    "commonstocksharesoutstanding": 3625000,
    "revenues": 32308735,
    "costofrevenue": 21993601,
    "grossprofit": 10315134,
    "sellingexpense": 6783703,
    "generalandadministrativeexpense": 2199657,
    "researchanddevelopmentexpense": 4858548,
    "operatingexpenses": 13841908,
    "operatingincomeloss": -3526774,
    "interestexpense": 156788,
    "otheroperatingincomeexpensenet": -235614,
    "investmentincomenet": 38530,
    "incomelossfromequitymethodinvestments": 31072,
    "othernonoperatingincomeexpense": -322800,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3849574,
    "incometaxexpensebenefit": 2313487,
    "netincomeloss": -6163061,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": 746561,
    "comprehensiveincomenetoftax": -6909622,
    "earningspersharebasic": -1.7,
    "weightedaveragenumberofsharesoutstandingbasic": 3625000,
    "earningspersharediluted": -1.7,
    "weightedaveragenumberofdilutedsharesoutstanding": 3625000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -746561,
    "depreciationdepletionandamortization": 508785,
    "gainlossondispositionofassets1": -114,
    "provisionfordoubtfulaccounts": -439327,
    "inventoryliforeserveperiodcharge": -49166,
    "deferredincometaxexpensebenefit": 679586,
    "increasedecreaseinaccountsreceivable": -4718118,
    "increasedecreaseininventories": 1183823,
    "increasedecreaseinprepaidsupplies": 170016,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1091022,
    "increasedecreaseinaccountspayable": 1641426,
    "increasedecreaseinaccruedincometaxespayable": 280939,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 244015,
    "netcashprovidedbyusedinoperatingactivities": 1120082,
    "paymentstoacquirepropertyplantandequipment": 44169,
    "netcashprovidedbyusedininvestingactivities": -44169,
    "proceedsfromshorttermdebt": 5671104,
    "repaymentsofbankdebt": 3969773,
    "proceedsfromrepaymentsofrelatedpartydebt": -3091977,
    "netcashprovidedbyusedinfinancingactivities": -1390646,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -111478,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -426211,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5285247,
    "interestpaidnet": 190184,
    "incometaxespaid": 863800,
    "advancestosuppliersnetpolicytextblock": "Advancesto suppliers, net",
    "heldtomaturityinvestmentpolicytextblock": "Short-term investments",
    "disaggregationofrevenuespolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b><i>Disaggregation of Revenues</i></b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><span style=\"background-color: white\">The Companydisaggregates its revenue from contracts by product types, as the Company believes it best depicts how the nature, amount, timing anduncertainty of the revenue and cash flows are affected by economic factors. </span></p>",
    "valueaddedtaxpolicytextblock": "Value added tax (“VAT”)",
    "statementofcashflowspolicytextblock": "Statementof Cash Flows",
    "employeedefinedcontributionplanpolicytextblock": "Employee Defined Contribution Plan",
    "propertyandequipmentestimatedusefullifetabletextblock": "Propertyand equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization of property and equipmentis provided using the straight-line method over their expected useful lives, as follows:",
    "scheduleofadvancestosuppliersnet": "Advancesto suppliers consist of the following:",
    "scheduleoffutureminimumcapitalexpenditurestabletextblock": "As of September30, 2023, future minimum capital expenditures on the Company’s CIP project are estimated as follows:",
    "scheduleofnatureofrelationshipswithrelatedpartiestabletextblock": "(a) Nature of relationships with related parties",
    "scheduleofduefromrelatedpartiestabletextblock": "(b) Due from related parties",
    "scheduleofduetorelatedpartiestabletextblock": "(c) Due to related parties",
    "scheduleoftaxpayabletabletextblock": "Taxes payable consist of thefollowing:",
    "entityincorporationdateofincorporation": "2019-12-11",
    "placeofincorporation": "Cayman Islands",
    "minorityinterestownershippercentagebyparent": 1,
    "entityprincipalactivities": "Investment holding",
    "propertyplantandequipmentusefullife": "P20Y",
    "finitelivedintangibleassetusefullife": "P50Y",
    "derivativeforwardexchangerate1": 1,
    "derivativeaverageforwardexchangerate1": 1,
    "accountsreceivablegrosscurrent": 11014909,
    "allowancefordoubtfulaccountsreceivable": 347306,
    "allowancefordoubtfulaccountsreceivablerecoveries": 439327,
    "allowancefordoubtfulaccountsreceivableperiodincreasedecrease": 5194,
    "inventoryrawmaterials": 635395,
    "inventoryfinishedgoods": 2777617,
    "inventoryadjustments": 69746,
    "inventoryrawmaterialsandsupplies": 180643,
    "increasedecreaseinaccruedinvestmentincomereceivable": 38530,
    "goodwillforeigncurrencytranslationgainloss": 31881,
    "propertyplantandequipmentgross": 7304936,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6050480,
    "finitelivedintangibleassetsgross": 246434,
    "finitelivedintangibleassetsaccumulatedamortization": 118537,
    "futureminimumcapitalexpenditurenexttwelvemonhs": 3392270,
    "futureminimumcapitalexpendituretwoyears": 8607456,
    "futureminimumcapitalexpenditurethreeyears": 1130756,
    "capitalexpenditurenet": 13130482,
    "natureofcommonownershipormanagementcontrolrelationships": "Chief Executive Officer and chairman of the Company’s Board of Directors",
    "currentincometaxexpensebenefit": 685937,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "effectiveincometaxratereconciliationtaxholidays": 0.081,
    "effectiveincometaxratereconciliationdispositionofbusiness": -0.001,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.02,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.141,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.048,
    "effectiveincometaxratereconciliationtaxcontingencies": -0.041,
    "deferredtaxassetsoperatinglosscarryforwards": 590283,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 66697,
    "deferredtaxassetstaxdeferredexpense": 656980,
    "deferredtaxassetsliabilitiesnet": 656980,
    "valueaddedtaxpayable": 303713,
    "othertaxespayable": 131045,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 26304448,
    "additionalpaidincapital": 29279159,
    "sellinggeneralandadministrativeexpense": -134141,
    "shortterminvestmentincome": 38530,
    "othernonoperatingexpense": -730,
    "temporaryequityforeigncurrencytranslationadjustments": -746561,
    "equityinearningsofsubsidiary": -6066720,
    "proceedsfromcontributionsfromaffiliates": 115133,
    "cashandcashequivalentsatcarryingvalue": 9248,
    "entityincorporationdatedescription": "March 2, 1998",
    "preferredstocksharesauthorized": 100000000,
    "preferredstockparorstatedvaluepershare": 0.003125,
    "allowanceforuncollectablebalancesamount": 347306,
    "inventoryvaluationreserves": 69747,
    "equitymethodinvestmentownershippercentage": 0.2,
    "equitymethodinvestmentsoldcarryingamount": 700000,
    "netinvestmentincome": 31072,
    "advertisingexpense": 4653633,
    "taxbenefitpercentage": 0.5,
    "percentageofvatrate": 0.13,
    "definedcontributionplancostrecognized": 440962,
    "netaccountreceivablepercentage": 0.586,
    "accountsreceivablenet": 6.5,
    "depreciation": 503687,
    "otherassetimpairmentcharges": 114,
    "amortizationofintangibleassets": 5098,
    "investmentbuildingandbuildingimprovements": 69200000,
    "capitalexpenditure": 95800000,
    "prepaymentfeesonadvancesnet": 16000000,
    "interestanddebtexpense": 190184,
    "prepaymentamount": 16000000,
    "effectiveincometaxratereconciliationtaxcontingenciesforeign": 0.165,
    "effectiveincometaxratereconciliationrepatriationofforeignearnings": 0.25,
    "taxespayablecurrentandnoncurrent": 309840,
    "incometaxholidayincometaxbenefitspershare": 0.09,
    "foreignfinancialinstitutionsmandateddeposits": 5223573,
    "concentrationriskpercentage1": 0.1,
    "ordinarysharesoutstandingdescription": "As a result of this forward split of theoutstanding ordinary shares at a ratio of 320-for-1 share, a total of 16,000,000 shares were issued and outstanding after the split.",
    "sharesissuedpricepershare": 0.003125,
    "cashdividenddescription": "A total of RMB130 million (approximately$19.1 million) cash dividend was declared from September 2016 to February 2019, among which, approximately RMB20 million ($3.1 million)was paid in cash to its shareholders in 2018 and the remaining RMB110 million ($16 million) was paid to its shareholders in 2019.",
    "statutorysurpluspercentage": 0.1,
    "reserveisequalpercentage": 0.5,
    "restrictedcash": 2439535,
    "futureminimumcapitalexpenditure": 13100000,
    "capitalexpendituresincurredbutnotyetpaid": 3400000,
    "minorityinterestsownershippercentagebyparent": 0.25,
    "entityregistrantname": "Universe Pharmaceuticals INC",
    "tradingsymbol": "UPC",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--09-30",
    "entitycommonstocksharesoutstanding": 3645974,
    "amendmentflag": "false",
    "entitycentralindexkey": 1809616,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-09-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40231",
    "entityincorporationstatecountrycode": "E9",
    "entityaddressaddressline1": "265 Jingjiu Avenue,",
    "entityaddressaddressline2": "Jinggangshan Economic and Technological Development Zone",
    "entityaddresscityortown": "Ji’an, Jiangxi",
    "entityaddresscountry": "CN",
    "entityaddresspostalzipcode": 343100,
    "contactpersonnelname": "Gang Lai",
    "cityareacode": 86,
    "localphonenumber": "86-0796-8403309",
    "contactpersonnelemailaddress": "Email: gang.lai@universe-pharmacy.com",
    "security12btitle": "Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorname": "YCM CPA, Inc.",
    "auditorfirmid": 6781,
    "auditorlocation": "Irvine, California"
  },
  {
    "date": "2022-09-30",
    "symbol": "UPC",
    "period": "FY",
    "cash": 28917,
    "shortterminvestments": 13148594,
    "accountsreceivablenetcurrent": 15183890,
    "inventorynet": 2206488,
    "supplies": 16701,
    "prepaymentforacquisitioncurrent": 3514450,
    "prepaidexpenseandotherassets": 1724099,
    "assetscurrent": 13177511,
    "propertyplantandequipmentnet": 4250638,
    "prepaymentsmadetoarelatedpartyforpurchaseofpropertynoncurrent": 2249248,
    "prepaymentsforconstructioninprogress": 9326296,
    "otherintangibleassetsnet": 157451,
    "investmentinequitysecurities": 702890,
    "deferredincometaxassetsnet": 1347672,
    "assetsnoncurrent": 18034195,
    "assets": 46442323,
    "shorttermbankloansandnotespayable": 3936184,
    "accountspayablecurrent": 3075393,
    "taxespayablecurrent": 167350,
    "duetorelatedpartiescurrent": 3379263,
    "otheraccruedliabilitiescurrent": 2539362,
    "liabilitiescurrent": 13097552,
    "commonstockvalue": 67969,
    "additionalpaidincapital": 29279159,
    "statutoryreserve": 2439535,
    "retainedearningsaccumulateddeficit": 18761900,
    "accumulatedothercomprehensiveincomelossnetoftax": -1666705,
    "stockholdersequity": 46442323,
    "liabilitiesandstockholdersequity": 46442323,
    "commonstockparorstatedvaluepershare": 0.003125,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 21750000,
    "commonstocksharesoutstanding": 21750000,
    "revenues": 40143151,
    "costofrevenue": 18251815,
    "grossprofit": 21891336,
    "sellingexpense": 19083135,
    "generalandadministrativeexpense": 2602624,
    "researchanddevelopmentexpense": 7644375,
    "operatingexpenses": 29330134,
    "incomefromoperation": 7438798,
    "interestexpense": 162400,
    "otheroperatingincomeexpensenet": 48940,
    "shortterminvestmentincome": 470477,
    "incomelossfromequitymethodinvestments": -7881455,
    "othernonoperatingincomeexpense": -545349,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -7984147,
    "incometaxexpensebenefit": 752419,
    "profitloss": -8736566,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": 3755464,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -12492030,
    "earningspersharebasic": -0.4,
    "weightedaveragenumberofsharesoutstandingbasic": 21750000,
    "earningspersharediluted": -0.4,
    "weightedaveragenumberofdilutedsharesoutstanding": 21750000,
    "sharesoutstanding": 21750000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -3755464,
    "netincomeloss": -8736566,
    "depreciationdepletionandamortization": 533949,
    "otherassetimpairmentcharges": 983,
    "provisionfordoubtfulaccounts": 419353,
    "inventoryliforeserveperiodcharge": 15774,
    "deferredincometaxexpensebenefit": -605278,
    "shortterminvestmentsincome": 470477,
    "increasedecreaseinaccountsreceivable": 1549312,
    "increasedecreaseininventories": -16586,
    "increasedecreaseinprepaidsupplies": -2681214,
    "increasedecreaseinprepaidadvertising": -7385695,
    "increasedecreaseinduefromrelatedparties": -236982,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1699929,
    "increasedecreaseinaccountspayable": -1896621,
    "increasedecreaseinpropertyandothertaxespayable": -904127,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 2318474,
    "netcashprovidedbyusedinoperatingactivities": -384634,
    "paymentstoacquirepropertyplantandequipment": 93703,
    "proceedsfromsaleofproductiveassets": 523,
    "paymentstoacquirebusinessesgross": 3814925,
    "netcashprovidedbyusedininvestingactivities": -3908105,
    "proceedsfromshorttermdebt": 4272716,
    "repaymentsofbankdebt": 4272716,
    "proceedsfromprepaymentsforrelatedpartiesborrowings": -3317943,
    "netcashprovidedbyusedinfinancingactivities": 303746,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -588,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -81476,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5711458,
    "interestpaidnet": 199852,
    "incometaxespaid": 2748629,
    "advancestosupplierstextblock": "NOTE 5 — ADVANCE TO SUPPLIERS ",
    "prepaymentforadvertistingtextblock": "NOTE 6 — PREPAYMENT FOR ADVERTISTING ",
    "prepaymentforacquisitiontextblock": "NOTE 7 — PREPAYMENT FOR ACQUISITION ",
    "heldtomaturityinvestmentdisclosuretextblock": "NOTE 8 — SHORT-TERM INVESTMENTS ",
    "prepaymentforconstructioninprogresstextblock": "NOTE 11 — PREPAYMENT FOR CIP PROJECT ",
    "prepaymentforpurchaseofapropertytextblock": "NOTE 12 — PREPAYMENT FOR PURCHASE OF A PROPERTY ",
    "advancestosuppliersnetpolicytextblock": "Advances to suppliers, net ",
    "heldtomaturityinvestmentpolicytextblock": "Short-term investments ",
    "contractassetsandliabilitiespolicytextblock": "Contract Assets and Liabilities ",
    "disaggregationofrevenuespolicytextblock": "Disaggregation of Revenues ",
    "valueaddedtaxpolicytextblock": "Value added tax (“VAT”) ",
    "statementofcashflowspolicytextblock": "Statement of Cash Flows ",
    "employeedefinedcontributionplanpolicytextblock": "Employee Defined Contribution Plan ",
    "propertyandequipmentestimatedusefullifetabletextblock": "            Useful life      Buildings     20 years      Machinery and equipment     5–10 years      Automobiles     3–5 years      Office and electric equipment     3–5 years   ",
    "scheduleofadvancestosuppliersnet": "            September 30,  2022      September 30,  2021       Advances to suppliers for inventory raw materials     $16,701      $2,738,313       Less: allowance for doubtful accounts      -       -       Advances to suppliers, net     $16,701      $2,738,313    ",
    "scheduleofduefromrelatedpartiestabletextblock": "            September 30,  2022      September 30,  2021       Name                    Greatest Group     $       -      $235,438       Foshan Shangyu      -       1,544       Total due from related parties     $-      $236,982    ",
    "scheduleofduetorelatedpartiestabletextblock": "            September 30,  2022      September 30,  2021       Name                    Mr. Gang Lai     $3,379,263      $-       Mrs. Lin Yang      -　       19,723       Total due to related parties     $3,379,263      $19,723    ",
    "scheduleoftaxpayabletabletextblock": "            September 30, 2022      September 30, 2021       Income tax payable     $-      $669,780       Value added tax payable      115,087       326,468       Other taxes payable      52,263       105,212       Total taxes payable     $167,350      $1,101,460   ",
    "entityincorporationdateofincorporation": "May 12, 2021",
    "placeofincorporation": "PRC",
    "ownershippercentage": "100%",
    "principalactivities": "Research and development of new pharmaceutical products",
    "propertyplantandequipmentusefullife": 5,
    "intermediatelifeplantsusefullife": 3,
    "descriptionofyearendspotrate": "US$1=RMB7.1135",
    "descriptionofaveragerate": "US$1=RMB6.5532",
    "accountsreceivablegrosscurrent": 15975717,
    "allowancefordoubtfulaccountsreceivablecurrent": 791827,
    "accountsreceivablebeforegrossvalue": 491208,
    "subsequentcollection": 152711,
    "percentageofsubsequentcollection": 0.311,
    "accountsreceivablegross": 15975717,
    "sunsequentcollectionstotalgrossaccountsreceivable": 10918976,
    "totalgrossaccountsreceivablepercentage": 0.6829999999999999,
    "accountsandfinancingreceivableallowanceforcreditloss": 791827,
    "accountsreceivablenet": 15183890,
    "sunsequentcollectionaccountsreceivablenet": 10918976,
    "accountsreceivablenetpercentage": 0.7190000000000001,
    "allowancefordoubtfulaccountsreceivable": 791827,
    "propertyplantandequipmentadditions": 419353,
    "temporaryequityforeigncurrencytranslationadjustments": -3755464,
    "inventoryrawmaterials": 989043,
    "inventoryfinishedgoods": 1337731,
    "inventoryvaluationreserves": 120286,
    "inventoryrawmaterialsandsupplies": 16701,
    "paymentstosuppliersandemployees": 16701,
    "increasedecreaseinaccruedinvestmentincomereceivable": -470477,
    "goodwillforeigncurrencytranslationgainloss": -106133,
    "propertyplantandequipmentgross": 9960736,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5710098,
    "finitelivedintangibleassetusefullife": 10,
    "finitelivedintangibleassetsgross": 273974,
    "finitelivedintangibleassetsaccumulatedamortization": -116523,
    "intangibleassetsnetexcludinggoodwill": 157451,
    "finitelivedintangibleassetsamortizationexpensenextrollingtwelvemonths": 5055,
    "finitelivedintangibleassetsamortizationexpenserollingyeartwo": 5055,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 5055,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 5055,
    "finitelivedintangibleassetsamortizationexpenserollingyearfive": 5055,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 132176,
    "finitelivedintangibleassetsnet": 13467372,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 3479306,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 9988066,
    "shorttermborrowings": 3936184,
    "relatedpartytransactiontermsandmannerofsettlement": "An affiliated entity of the Company, 90% owned by and controlled by the Company’s Chief Executive Officer",
    "duetorelatedpartiesnoncurrent": 3379263,
    "currentincometaxexpensebenefit": 1357697,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "effectiveincometaxratereconciliationtaxholidays": 0.087,
    "effectiveincometaxratereconciliationdispositionofbusiness": -0.223,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.034,
    "effectiveincometaxratecontinuingoperations": -0.094,
    "deferredtaxassetsoperatinglosscarryforwards": 1210855,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 136817,
    "deferredtaxassetsliabilitiesnet": 1347672,
    "deferredtaxassetsgross": 1347672,
    "salesandexcisetaxpayablecurrent": 115087,
    "accrualfortaxesotherthanincometaxescurrent": 52263,
    "costofotherpropertyoperatingexpense": 23988177,
    "costofgoodsandservicessold": 16154974,
    "subtotaloftcmdproductssales": 23988177,
    "subtotalofthirdpartyproductssales": 16154974,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 33264812,
    "sellinggeneralandadministrativeexpense": 384214,
    "interestexpenseothershorttermborrowings": 470477,
    "othernoncashincomeexpense": -420,
    "comprehensiveincomenetoftaxattributabletononcontrollinginterest": -12492030,
    "equityinearningsofsubsidiary": 7881455,
    "investmentincomenet": 470477,
    "proceedsfromcontributionsfromaffiliates": 303746,
    "cashcashequivalentrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 28917,
    "entityincorporationdatedescription": "(“JiangxiUniverse”) was incorporated on March 2, 1998 in accordance with PRC laws and is engaged in research and development and manufacturingof modernized traditional Chinese medicines.",
    "equitymethodinvestmentownershipspercentage": 1.1,
    "amountofregisteredcapital": 4300000,
    "materialpricepercentage": 0.05,
    "paymentterm": 120,
    "allowanceforuncollectablebalancesamount": 791827,
    "equitymethodinvestmentsoldcarryingamount": 702890,
    "netinvestmentincome": 38588,
    "advertisingexpense": 17527318,
    "taxbenefitpercentage": 0.5,
    "percentageofvatrate": 0.17,
    "definedcontributionplancostrecognized": 465689,
    "contractpricepercentage": 0.12,
    "revenueremainingperformanceobligation": 6600000,
    "othershortterminvestments": 470477,
    "depreciation": 528919,
    "gainlossondispositionofassets1": 983,
    "amortizationofintangibleassets": 5030,
    "investmentbuildingandbuildingimprovements": 69200000,
    "constructioncontractcostprogresspaymentoffset": 2900000,
    "prepayment": 9300000,
    "capitalexpenditure": 3500000,
    "prepaymentfeesonadvancesnet": 16000000,
    "interestanddebtexpense": 199852,
    "prepaymentamount": 16000000,
    "effectiveincometaxratereconciliationtaxcontingenciesforeign": 0.165,
    "effectiveincometaxratereconciliationrepatriationofforeignearnings": 0.25,
    "taxespayablecurrentandnoncurrent": 694955,
    "incometaxholidayincometaxbenefitspershare": 0.03,
    "foreignfinancialinstitutionsmandateddeposits": 5711423,
    "concentrationriskthresholdpercentage": 0.10300000000000001,
    "sharesissued": 300000,
    "ordinarysharesoutstandingdescription": "As a result of this forward split ofthe outstanding ordinary shares at a ratio of 320-for-1 share, a total of 16,000,000 shares were issued and outstanding after the split.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.001,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpecteddividendrate": 0.06,
    "warrantexercisepriceincrease": 5.5,
    "saleofstockpricepershare": 5,
    "cashdividenddescription": "A total of RMB130 million (approximately $19.1 million) cash dividend was declared from September2016 to February 2019, among which, approximately RMB20 million ($3.1 million) was paid in cash to its shareholders in 2018 and the remainingRMB110 million ($16 million) was paid to its shareholders in 2019.",
    "statutorysurpluspercentage": 0.1,
    "reserveisequalpercentage": 0.5,
    "restrictedcash": 2439535,
    "cashequivalentsatcarryingvalue": 5211231,
    "capitalexpenditurediscontinuedoperations": 13500000,
    "interestexpensecapitalsecurities": 3500000,
    "numberofreportablesegments": 1,
    "subsequenteventdescription": "The Company evaluated the subsequent event throughthe date of this report, and concluded that there are no material reportable subsequent events need to be disclosed.",
    "minorityinterestsownershippercentagebyparent": 0.25,
    "entityregistrantname": "UniversePharmaceuticals INC",
    "tradingsymbol": "UPC",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "September 30",
    "entitycommonstocksharesoutstanding": 21750000,
    "amendmentflag": "false",
    "entitycentralindexkey": 1809616,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "September 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "No",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40231",
    "entityincorporationstatecountrycode": "CaymanIslands",
    "entityaddressaddressline1": "265Jingjiu Avenue",
    "entityaddressaddressline2": "Jinggangshan Economic and Technological Development Zone",
    "entityaddresscityortown": "Ji’an,Jiangxi Province",
    "entityaddresscountry": "China",
    "entityaddresspostalzipcode": 343100,
    "contactpersonnelname": "GangLai",
    "contactpersonnelemailaddress": "gang.lai@universe-pharmacy.com",
    "security12btitle": "Ordinary Shares",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorname": "YCM CPA, Inc.",
    "auditorfirmid": 6781,
    "auditorlocation": "Irvine, California",
    "cityareacode": 86,
    "localphonenumber": "0796-8403309"
  },
  {
    "date": "2021-09-30",
    "symbol": "UPC",
    "period": "FY",
    "cash": 110393,
    "shortterminvestments": 13725204,
    "receivablesnetcurrent": 15573742,
    "inventorynet": 2462542,
    "duefromrelatedparties": 236982,
    "advancetosuppliersnet": 2738313,
    "prepaymentforadvertising": 7492320,
    "prepaidexpenseandotherassets": 174053,
    "assetscurrent": 13835597,
    "propertyplantandequipmentnet": 4681353,
    "prepaymentsmadetoarelatedpartyforpurchaseofpropertynoncurrent": 2476800,
    "prepaymentsforconstructioninprogress": 10712160,
    "otherintangibleassetsnet": 178483,
    "investmentinequitysecurities": 744924,
    "deferredincometaxassetsnet": 869997,
    "assetsnoncurrent": 19663717,
    "assets": 58934353,
    "shorttermbankloansandnotespayable": 4334400,
    "accountspayablecurrent": 5310526,
    "taxespayablecurrent": 1101460,
    "duetorelatedpartiescurrent": 19723,
    "otheraccruedliabilitiescurrent": 444319,
    "liabilitiescurrent": 11210428,
    "commonstockvalue": 67969,
    "additionalpaidincapital": 29279159,
    "statutoryreserve": 2439535,
    "retainedearningsaccumulateddeficit": 27498466,
    "accumulatedothercomprehensiveincomelossnetoftax": 2088759,
    "stockholdersequity": 58934353,
    "liabilitiesandstockholdersequity": 58934353,
    "commonstockparorstatedvaluepershare": 0.003125,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 21750000,
    "commonstocksharesoutstanding": 21750000,
    "revenues": 47982031,
    "costofrevenue": 22655854,
    "grossprofit": 25326177,
    "sellingexpense": 2973531,
    "generalandadministrativeexpense": 3296844,
    "researchanddevelopmentexpense": 5465662,
    "operatingexpenses": 11736037,
    "operatingincomeloss": 13590140,
    "interestexpense": 101604,
    "otheroperatingincomeexpensenet": -80434,
    "shortterminvestmentincome": -239549,
    "incomelossfromequitymethodinvestments": 12319023,
    "othernonoperatingincomeexpense": 88338,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 13678478,
    "incometaxexpensebenefit": 2358526,
    "profitloss": 11319952,
    "othercomprehensiveincomelossforeigncurrencytranslationadjustmenttax": -1193369,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": 12513321,
    "earningspersharebasicanddiluted": 0.6,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 18980822,
    "sharesoutstanding": 21750000,
    "stockissuedduringperiodvaluenewissues": 28750000,
    "stockissuedduringperiodsharesnewissues": 5750000,
    "stockissuedduringperiodvaluecapitalizedinitialpublicofferingcosts": -3131872,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 1193369,
    "depreciationandamortization": 446878,
    "gainlossondispositionofassets1": -1559,
    "provisionfordoubtfulaccounts": -230175,
    "deferredincometaxexpensebenefit": -668341,
    "interestincomeshortterminvestmentother": 239549,
    "increasedecreaseinaccountsreceivable": 3867457,
    "increasedecreaseininventories": 451634,
    "increasedecreaseinprepaidsupplies": 2717085,
    "increasedecreaseinprepaidadvertising": 7434240,
    "increasedecreaseinduefromrelatedparties": 237720,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 168188,
    "increasedecreaseinaccountspayable": 2457337,
    "increasedecreaseinpropertyandothertaxespayable": -298620,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 31436,
    "netcashprovidedbyusedinoperatingactivities": -999075,
    "paymentstoacquirepropertyplantandequipment": 444505,
    "prepaymentsmadetoarelatedpartyforpurchaseofproperty": 2457600,
    "repaymentsofadvancesforconstruction": 10629120,
    "paymentsforproceedsfromshortterminvestments": -15330660,
    "redemptionofshortterminvestments": 1801927,
    "netcashprovidedbyusedininvestingactivities": -13528733,
    "proceedsfromshorttermdebt": 4300800,
    "repaymentsofbankdebt": 2764800,
    "proceedsfromissuanceinitialpublicoffering": 28750000,
    "paymentsforrepurchaseofinitialpublicoffering": 2792543,
    "proceedsfromprepaymentsforrelatedpartiesborrowings": 911648,
    "netcashprovidedbyusedinfinancingactivities": 14598693,
    "effectofexchangerateoncashandcashequivalents": 39508,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 110393,
    "cashandcashequivalentsatcarryingvalue": 8077908,
    "interestpaidnet": 149303,
    "incometaxespaid": 3271219,
    "advancestosupplierstextblock": "NOTE 5 — ADVANCE TO SUPPLIERS ",
    "prepaymentforadvertistingtextblock": "NOTE 6 — PREPAYMENT FOR ADVERTISTING ",
    "heldtomaturityinvestmentdisclosuretextblock": "NOTE 7 — SHORT-TERM INVSTMENTS ",
    "prepaymentforconstructioninprogresstextblock": "NOTE 10 — PREPAYMENT FOR CONSTRUCTION-IN-PROGRESS(“CIP”) PROJECT  ",
    "prepaymentforpurchaseofapropertytextblock": "NOTE 11 — PREPAYMENT FOR PURCHASE OFA PROPERTY  ",
    "advancestosuppliersnetpolicytextblock": "Advancesto suppliers, net ",
    "heldtomaturityinvestmentpolicytextblock": "Short-term investments ",
    "contractassetsandliabilitiespolicytextblock": "ContractAssets and Liabilities  ",
    "disaggregationofrevenuespolicytextblock": "Disaggregationof Revenues ",
    "valueaddedtaxpolicytextblock": "Valueadded tax (“VAT”) ",
    "statementofcashflowspolicytextblock": "Statementof Cash Flows ",
    "employeedefinedcontributionplanpolicytextblock": "EmployeeDefined Contribution Plan ",
    "propertyandequipmentestimatedusefullifetabletextblock": "                Useful    life       Buildings          20 years       Machinery and equipment             5–10 years       Automobiles          3–5 years       Office and electric equipment             3–5 years    ",
    "scheduleofadvancestosuppliersnet": "            September 30, 2021      September 30, 2020       Advances to suppliers for inventory raw material purchase     $2,738,313      $           -       Less: allowance for doubtful accounts      -       -       Advances to suppliers     $2,738,313      $-    ",
    "scheduleofduefromrelatedpartiestabletextblock": "      Name     September 30,  2021      September 30,  2020       Greatest Group     $235,438      $      -       Foshan Shangyu      1,544       -       Total due from related parties     $236,982      $-    ",
    "scheduleofduetorelatedpartiestabletextblock": "      Name     September 30,  2021      September 30,  2020       Mr. Gang Lai     $-      $956,492       Mrs. Lin Yang      19,723       -　       Total due to related parties     $19,723      $956,492    ",
    "scheduleoftaxpayabletabletextblock": "            September 30,  2021      September 30,  2020       Income tax payable     $669,780      $767,297       Value added tax payable      326,468       433,838       Other taxes payable      105,212       130,614       Total taxes payable     $1,101,460      $1,331,749   ",
    "entityincorporationdateofincorporation": "May 12, 2021",
    "placeofincorporation": "PRC",
    "equitymethodinvestmentownershippercentage": 1.1,
    "principalactivities": "Research and development of new pharmaceutical products",
    "propertyplantandequipmentusefullife": 5,
    "finitelivedintangibleassetusefullife": 3,
    "descriptionofyearendspotrate": "US$1=RMB 6.4580",
    "descriptionofaveragerate": "US$1=RMB 6.5095",
    "accountsreceivablegrosscurrent": 16020269,
    "allowancefordoubtfulaccountsreceivablecurrent": 446527,
    "accountsreceivablenetcurrent": 15573742,
    "accountsreceivablebeforegrossvalue": 88162,
    "subsequentcollection": 584,
    "percentageofsubsequentcollection": 0.006999999999999999,
    "accountsreceivablegross": 16020269,
    "sunsequentcollectionstotalgrossaccountsreceivable": 11739179,
    "totalgrossaccountsreceivablepercentage": 0.733,
    "accountsandfinancingreceivableallowanceforcreditloss": 446527,
    "accountsreceivablenet": 15573742,
    "sunsequentcollectionaccountsreceivablenet": 11739179,
    "accountsreceivablenetpercentage": 0.7540000000000001,
    "allowancefordoubtfulaccountsreceivable": 446527,
    "unrecognizedtaxbenefitsreductionsresultingfromlapseofapplicablestatuteoflimitations": 225660,
    "temporaryequityforeigncurrencytranslationadjustments": 1193369,
    "inventoryrawmaterials": 607661,
    "inventoryfinishedgoods": 1971334,
    "inventoryvaluationreserves": 116453,
    "inventoryrawmaterialsandsupplies": 2738313,
    "paymentstosuppliersandemployees": 2738313,
    "addpurchasewealthmanagementfinancialproducts": 15330660,
    "paymentstoacquireshortterminvestments": 1801927,
    "increasedecreaseinaccruedinvestmentincomereceivable": 239549,
    "goodwillforeigncurrencytranslationgainloss": -43078,
    "propertyplantandequipmentgross": 10461600,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5780247,
    "finitelivedintangibleassetsgross": 301691,
    "finitelivedintangibleassetsaccumulatedamortization": -123208,
    "intangibleassetsnetexcludinggoodwill": 178483,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 9721440,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 5567,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 5567,
    "finitelivedintangibleassetsamortizationexpenserollingyearfive": 5567,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearsix": 5567,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 150648,
    "finitelivedintangibleassetsnet": 14829840,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 3831300,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1277100,
    "shorttermborrowings": 4334400,
    "relatedpartytransactiontermsandmannerofsettlement": "An affiliated entity of the Company, 90% owned by and controlled by the Company’s CEO.",
    "duefromotherrelatedpartiescurrent": 236982,
    "duetorelatedpartiesnoncurrent": 19723,
    "currentincometaxexpensebenefit": 3026867,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "effectiveincometaxratereconciliationtaxholidays": 0.11,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.02,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.005,
    "effectiveincometaxratecontinuingoperations": 0.171,
    "deferredtaxassetsoperatinglosscarryforwards": 785550,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 84447,
    "deferredtaxassetsliabilitiesnet": 869997,
    "deferredtaxassetsgross": 869997,
    "accruedincometaxescurrent": 669780,
    "salesandexcisetaxpayablecurrent": 326468,
    "accrualfortaxesotherthanincometaxescurrent": 105212,
    "costofotherpropertyoperatingexpense": 29559286,
    "costofgoodsandservicessold": 18422745,
    "subtotaloftcmdproductssales": 29559286,
    "subtotalofthirdpartyproductssales": 18422745,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 45098756,
    "sellinggeneralandadministrativeexpense": -1177869,
    "interestexpenseothershorttermborrowings": 239549,
    "othernoncashincomeexpense": -60751,
    "comprehensiveincomenetoftaxattributabletononcontrollinginterest": 12513321,
    "equityinearningsofsubsidiary": -12319027,
    "proceedsfromissuanceofcommonstock": 25957457,
    "cashlenttosubsidiaries": -11358764,
    "cashandcashequivalentatcarryingvalue": 110393,
    "entityincorporationdatedescription": "(“Jiangxi Universe”) was incorporated on March 2, 1998 in accordance with PRC laws andis engaged in research and development and manufacturing of modernized traditional Chinese medicines.",
    "amountofregisteredcapital": 4300000,
    "allowanceforuncollectablebalancesamount": 446527,
    "deferredofferingcosts": 2792543,
    "equitymethodinvestmentsoldcarryingamount": 744924,
    "netinvestmentincome": 30827,
    "advertisingexpense": 1316654,
    "percentageofvatrate": 0.17,
    "definedcontributionplancostrecognized": 617145,
    "rawmaterialspurchased": 0.6609999999999999,
    "debtinstrumentannualprincipalpayment": 48400000,
    "revenueremainingperformanceobligation": 6600000,
    "othershortterminvestments": 239549,
    "depreciation": 441355,
    "amortizationofintangibleassets": 5523,
    "investmentbuildingandbuildingimprovements": 69200000,
    "prepayment": 10700000,
    "capitalexpenditure": 3800000,
    "prepaymentfeesonadvancesnet": 16000000,
    "interestanddebtexpense": 149303,
    "effectiveincometaxratereconciliationtaxcontingenciesforeign": 0.165,
    "effectiveincometaxratereconciliationrepatriationofforeignearnings": 0.25,
    "taxespayablecurrentandnoncurrent": 1518979,
    "incometaxholidayincometaxbenefitspershare": 0.09,
    "foreignfinancialinstitutionsmandateddeposits": 5892655,
    "concentrationriskthresholdpercentage": 0.1,
    "ordinarysharesoutstandingdescription": "As a result of this forward splitof the outstanding ordinary shares at a ratio of 320-for-1 share, there is a total of 16,000,000 shares issued and outstanding.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 5.5,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpecteddividendrate": 0.06,
    "saleofstockpricepershare": 5,
    "restrictedcash": 2439535,
    "restrictednetassets": 31786663,
    "capitalexpenditurediscontinuedoperations": 14800000,
    "interestexpensecapitalsecurities": 3800000,
    "numberofreportablesegments": 1,
    "minorityinterestsownershippercentagebyparent": 0.25,
    "entityregistrantname": "UniversePharmaceuticals INC",
    "tradingsymbol": "UPC",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--09-30",
    "entitycommonstocksharesoutstanding": 21750000,
    "amendmentflag": "false",
    "entitycentralindexkey": 1809616,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "September 30, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "No",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-40231",
    "entityincorporationstatecountrycode": "CaymanIslands",
    "entityaddressaddressline1": "265Jingjiu Avenue",
    "entityaddressaddressline2": "Jinggangshan Economic and Technological Development Zone",
    "entityaddresscityortown": "Ji’an,Jiangxi Province",
    "entityaddresscountry": "China",
    "contactpersonnelname": "GangLai",
    "contactpersonnelemailaddress": "gang.lai@universe-pharmacy.com",
    "security12btitle": "Ordinary Shares",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "cityareacode": 86,
    "localphonenumber": "0796-8403309"
  }
]